Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
തുറക്കുക
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
TEVA:TLV
Teva Pharmaceutical Industries Ltd
ILA 10,290.00
-0.87%
(-90.00) 1D
മേയ് 1, ജിഎംടി+3 1:46:30 PM  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for TEVA...
തുറക്കുക
ILA 10,320.00
High
ILA 10,370.00
Low
ILA 10,260.00
Mkt. cap
൪൦.൪൩B
Avg. vol.
൯൮൭.൫൮K
Volume
൪൪൭.൬൦K
P/E ratio
൨൫.൮൨
52-wk high
ILA 11,350.00
52-wk low
ILA 5,305.00
EPS
ILA 3.99
Shares outstanding
൧.൧൬B
No. of employees
൩൨K
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
6 മണിക്കൂർ മുമ്പ്
Teva Pharmaceutical Industries Q1 Earnings Call Highlights
GuruFocus
GuruFocus
·
1 ദിവസം മുമ്പ്
TEVA SWOT Analysis: Financial Resilience Amidst Challenges Revea
MarketBeat
MarketBeat
·
2 ദിവസം മുമ്പ്
Truist Financial Increases Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $45.00
Zacks Investment Research
Zacks Investment Research
·
2 ദിവസം മുമ്പ്
TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock Up
പ്രൊഫൈൽ
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Ltd
CEOറിച്ചാർഡ് ഫ്രാൻസിസ്
Employees32K
Founded1944 ഫെബ്രു 13
Headquarters-
Sector-
Websiteteva.co.il
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ജൂൺ
2025 സെപ്റ്റം
2025 ഡിസം
2026 മാർ
Revenue
4.18B
4.48B
4.71B
3.98B
Cost of goods sold
2.07B
2.18B
2.06B
2.01B
Cost of revenue
2.07B
2.18B
2.06B
2.01B
Research and development expenses
244.00M
256.00M
267.00M
222.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
959.00M
973.00M
1.12B
1.00B
Operating expense
1.21B
1.24B
1.37B
1.21B
Total operating expenses
3.28B
3.41B
3.43B
3.22B
Operating income
894.00M
1.07B
1.28B
758.00M
Other non operating income
-90.00M
-27.00M
-
1.00M
EBT including unusual items
204.00M
648.00M
90.00M
436.00M
EBT excluding unusual items
643.00M
832.00M
1.08B
542.00M
Income tax expense
-78.00M
214.00M
-390.00M
67.00M
Effective tax rate
-38.24%
33.02%
-433.33%
15.37%
Other operating expenses
5.00M
9.00M
-17.00M
-9.00M
Net income
282.00M
433.00M
480.00M
369.00M
Net profit margin
6.75%
9.67%
10.19%
9.27%
Earnings per share
0.66
0.78
0.96
0.53
Interest and investment income
-
-
92.00M
-
Interest expense
-220.00M
-205.00M
-280.00M
-216.00M
Net interest expenses
-220.00M
-205.00M
-188.00M
-216.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.14B
1.32B
1.54B
997.00M
Gain or loss from assets sale
-2.00M
-
-
-8.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer